Concepedia

Publication | Open Access

Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study

DOIFull Paper Access

99

Citations

14

References

2016

Year

Robert Flisiak, Ewa Janczewska, Marta Wawrzynowicz‐Syczewska, Jerzy Jaroszewicz, Dorota Zarębska‐Michaluk, Khalil Nazzal, Beata Bolewska, Hanna Berak, Katarzyna Fleischer‐Stępniewska, Krzysztof Tomasiewicz,
Alimentary Pharmacology & Therapeutics

Abstract

The results of our study confirm previous findings. They demonstrate excellent effectiveness and a good safety profile of OBV/PTV/r± DSV±RBV in HCV genotype 1-infected patients treated in the real-world setting.

References

YearCitations

Page 1